Immune thrombocytopenic purpura (ITP) is an autoimmune disorder where antibodies target platelets, leading to their destruction in the spleen and resulting in reduced platelet counts. It often presents…
In an interview conducted at the 2024 American Society of Hematology Annual Meeting in San Diego, California, Prithviraj Bose, MD, The University of Texas MD Anderson Cancer Center,…
NEW YORK (Reuters Health) – In patients with systemic lupus erythematosus (SLE), the antimalarial drugs chloroquine and hydroxychloroquine have wide-ranging benefits and a good safety profile, published studies…
NEW YORK (Reuters Health) – An investigational drug called motavizumab may offer better protection against respiratory syncytial virus (RSV) than palivizumab in high risk children, according to a…
NEW YORK (Reuters Health) – In patients receiving glucocorticoids for inflammatory diseases, adverse events are very common, even at low to medium doses, according to a meta-analysis by…
NEW YORK (Reuters Health) – Anti-tumor necrosis factor (TNF) agents do not increase the risk of cancer during the first few years of use for rheumatoid arthritis, according…
NEW YORK (Reuters Health) – In a follow-up study of Alaska Natives who received plasma-derived hepatitis B vaccine when they were more than 6 months old, a large…
NEW YORK (Reuters Health) – Prophylactic use of acetaminophen during vaccination in children can reduce febrile reactions, but unfortunately the antibody responses to various vaccine antigens are weakened,…
NEW YORK (Reuters Health) – Elevated levels of high-sensitivity C-reactive protein (hsCRP), an inflammatory marker, predicted mortality and myocardial infarction but not stroke in a multiethnic cohort. “Our…
NEW YORK (Reuters Health) – In young women, the presence of lupus anticoagulant is associated with a more than 40-fold increased risk of stroke and 5-fold increased risk…
NEW YORK (Reuters Health) – There is “compelling evidence” for a benefit of statins in chronic obstructive pulmonary disease (COPD), but the evidence is not yet strong enough…
NEW YORK (Reuters Health) – During the 2007-2008 flu season, the licensed inactivated flu vaccine was 50% more effective than the live attenuated vaccine in preventing laboratory-confirmed symptomatic…
